| Breakdown | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 142.01B | 136.30B | 128.74B | 115.48B | 104.02B |
| Gross Profit | 34.18B | 32.17B | 31.30B | 26.17B | 26.76B |
| EBITDA | 19.14B | 18.79B | 16.46B | 12.77B | 15.01B |
| Net Income | 4.40B | 2.72B | 2.57B | -2.21B | 1.90B |
Balance Sheet | |||||
| Total Assets | 209.43B | 196.66B | 188.37B | 173.32B | 166.16B |
| Cash, Cash Equivalents and Short-Term Investments | 29.47B | 29.15B | 30.96B | 24.11B | 23.02B |
| Total Debt | 65.89B | 65.79B | 63.38B | 61.93B | 57.13B |
| Total Liabilities | 118.01B | 114.56B | 109.64B | 102.86B | 97.45B |
| Stockholders Equity | 82.09B | 72.75B | 68.82B | 61.14B | 60.34B |
Cash Flow | |||||
| Free Cash Flow | 4.09B | 342.00M | 8.67B | -162.00M | 6.27B |
| Operating Cash Flow | 13.72B | 10.92B | 16.66B | 5.00B | 13.21B |
| Investing Cash Flow | -7.82B | -8.39B | -8.30B | -6.34B | -8.07B |
| Financing Cash Flow | -4.77B | -2.39B | -2.50B | 790.00M | -5.08B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | ¥164.16B | 8.85 | ― | 4.47% | 1.64% | 19.87% | |
75 Outperform | ¥216.93B | 15.87 | 7.50% | 5.39% | -1.82% | 23.07% | |
74 Outperform | ¥74.52B | 9.32 | 5.20% | 3.67% | 6.47% | 40.87% | |
73 Outperform | ¥88.95B | 6.59 | ― | 4.95% | -1.72% | 8.59% | |
67 Neutral | ¥56.53B | 12.92 | 5.33% | 2.09% | 4.19% | 62.47% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
54 Neutral | ¥320.25B | 253.27 | ― | 1.93% | <0.01% | -83.75% |